Background-The association between low socioeconomic status (SES) and high mortality from coronary heart disease is well-known. However, the role of SES in relation to the clinical outcome after primary percutaneous coronary intervention remains poorly understood. Methods and Results-We studied 7385 patients treated with primary percutaneous coronary intervention. Participants were divided into high-SES and low-SES groups according to income, education, and employment status. The primary outcome was major adverse cardiac events (cardiac death, recurrent myocardial infarction, and target vessel revascularization) at maximum follow-up (mean, 3.7 years). Low-SES patients had more adverse baseline risk profiles than high-SES patients. The cumulative risk of major adverse cardiac events after maximum follow-up was higher among low-income patients and unemployed patients compared with their counterparts (income: hazard ratio, 1.68; 95% CI, 1.47-1.92; employment status: hazard ratio, 1.75; 95% CI, 1.46-2.10). After adjustment for patient characteristics, these differences were substantially attenuated (income: hazard ratio, 1.12; 95% CI, 0.93-1.33; employment status: hazard ratio, 1.27; 95% CI, 1.03-1.56). Further adjustment for admission findings, procedure-related data, and medical treatment during followup did not significantly affect the associations. With education as the SES indicator, no between-group differences were observed in the risk of the composite end point. Conclusions-Even in a tax-financed healthcare system, low-SES patients treated with primary percutaneous coronary intervention face a worse prognosis than high-SES patients. The poor outcome seems to be largely explained by differences in baseline patient characteristics. 
T here is a well-known association between low socioeconomic status (SES) and high incidence of and mortality from coronary heart disease. 1, 2 One possible explanation is the inverse relationship between SES and the prevalence of almost all well-established cardiovascular risk factors. 3 Furthermore, existing literature suggests that SES-related differences may exist in quality of care, with low-SES patients receiving fewer relevant diagnostic examinations and less care than patients with high SES (eg, coronary arteriography, coronary intervention, and evidence-based medical treatment). 2, [4] [5] [6] Primary percutaneous coronary intervention (PPCI) is the recommended treatment for ST-elevation myocardial infarction (STEMI). The efficacy of PPCI has been documented in several randomized controlled trials comparing PPCI with thrombolysis. 7, 8 There also appear to be SES-related differences in care among STEMI patients; several studies have observed that low-SES patients eligible for PPCI are less likely to receive the treatment than their high-SES counterparts. 2, 4, 5 However, the exact role of SES in relation to post-STEMI outcomes remains poorly understood. Most studies on this topic neither provide detailed individual-level data about SES nor explore different dimensions of SES. 2, 4, 6, 9 They also include only limited details about patient and treatment characteristics, 2, 9 making it difficult to clarify the mechanisms driving the possibly SES-related differences in clinical outcomes. Furthermore, no studies include follow-up information about medical treatment beyond 90 days after hospital discharge, although differences in long-term adherence to secondary medical prophylaxis may potentially be an important factor underlying SES-related differences in clinical outcomes. 1, 5, 6, 10 We, therefore, conducted a follow-up study of PPCI-treated patients from Denmark, a country that provides tax-financed health care to all residents and considers PPCI as the standard treatment for STEMI, which should theoretically guarantee equal access to treatment independent of individual SES. We compared patient and treatment characteristics, as well as short-and long-term outcomes after PPCI according to SES in unselected real-world patients.
Methods
We completed a population-based, historical follow-up study in the Western part of Denmark with ≈3.3 million inhabitants (56% of the Danish population). The Danish National Health Service provides tax-financed health care, guaranteeing unfettered access to medical care. All acute medical conditions are treated exclusively at public hospitals. The Danish Civil Registration System keeps records of sex, date of birth, and changes in vital status. The records carry each patient's unique civil registration number, which is used for all Danish registries, thereby enabling unambiguous record linkage among registries.
Identification of Patients
PPCI has been implemented as the standard treatment for STEMI in Denmark since the DANAMI-2 (Danish Trial in Acute Myocardial Infarction-2) trial, 8 and Danish STEMI patients are almost exclusively treated with PPCI. The Western Denmark Heart Registry collects detailed data related to patients and procedures for all interventions conducted in the 3 coronary intervention centers in West Denmark: Odense University Hospital, Aarhus University Hospital (Skejby), and Aarhus University Hospital (Aalborg). Reporting to the registry is mandatory, and data quality is ensured by automatic validation rules at data entry, combined with systematic validation procedures and random spot-checks of data after entry. 11 We identified all Danish STEMI patients from 2002 to 2008 who underwent PPCI within 12 hours of symptom onset (n=7385).
Socioeconomic Status
The Integrated Database for Labor Market Research collects individual-level socioeconomic data on Danish citizens. From the Integrated Database for Labor Market Research, we obtained information about employment status the year before hospital admission for each patient (employed, unemployed, or pensioner). Pensioner indicates that the patient received a pension, an early retirement benefit, or was otherwise economically inactive.
We also retrieved personal income information for each patient and cohabiting partner, including imputed rent for owner-occupied dwellings, interests received, pension withdrawals, unemployment benefits, and other social security benefits. This broad definition of income was used in an attempt to reflect the wealth of each patient because it has been suggested that wealth is a more sensitive indicator of SES than income. 12 We calculated the combined average income of each patient and their cohabiting partner in the 5 years before admission. All patients were divided into tertiles of increasing income. Information regarding the highest completed level of education as registered the year before admission was obtained from the Student Registry of Statistics Denmark. Patients were divided into 3 groups: long (short-, medium-, and long-term higher education), medium (vocational education, upper or lower secondary school), and short (primary school).
Patient and Treatment Characteristics
We obtained data about hypertension, smoking status, Killip class on admission, duration of symptoms, and all procedure-related data from the Western Denmark Heart Registry.
The Danish National Patient Registry collects data for all hospitalizations at Danish hospitals, including dates of admission and discharge and discharge diagnoses coded according to the International Classification of Diseases (10th revised edition since 1993). Based on the past 10 years of each patient's hospitalization history, we computed the Charlson Comorbidity Index score that has been validated for the prediction of mortality for patients with a wide range of conditions 13 and has been validated for use with hospital discharge registry data. 14 We defined 3 levels of comorbidity: a score of 0 (low), a score of 1 to 2 (moderate comorbidity), and a score of >2 (high comorbidity).
The Danish Transfusion Database is a national registry monitoring the use of all blood components. We obtained information regarding the types and number of blood components administered to the patients from the day of admission to 7 days postadmission.
We obtained data regarding the use of cardiovascular drugs from the Danish Medicines Agency's Register of Medicinal Product Statistics, a national prescription registry that contains information on all redeemed prescriptions for reimbursable drugs dispensed from all pharmacies in Denmark. The information includes type of drug (according to the Anatomic Therapeutic Chemical classification system) and date dispensed. We identified all prescriptions for aspirin, clopidogrel, nitroglycerin, statins, angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and selective and nonselective β-blockers filled until 2 years after hospital discharge. All the drugs were available only by prescription, except for aspirin. However, aspirin is available by prescription, and patients with chronic diseases and pensioners are reimbursed for it.
For a subset of patients (n=4856), data from the Laboratory Information Systems in the Central Denmark and North Denmark Regions were obtained, including data regarding hemoglobin, serum creatinine level, total cholesterol, troponin T, and the creatine kinasemyocardial band. For all laboratory values, the highest value measured over 7 days, starting from the time of admission, was obtained except for hemoglobin where the lowest value was obtained. We calculated the estimated glomerular filtration rate using the 4-component modification of diet in renal disease equation incorporating age, race, sex, and serum creatinine level. 15 Race was not included because race data were unavailable. Based on hemoglobin values, we classified anemia into categories for men and women as follows: no anemia (men, >8. 
WHAT IS KNOWN
• There is a well-known association between low socioeconomic status (SES) and high incidence of and mortality from coronary heart disease.
• There also appear to be SES-related differences in care among ST-elevation myocardial infarction patients, but the exact role of SES in relation to post-ST-elevation myocardial infarction outcomes remains poorly understood.
WHAT THE STUDY ADDS
• Even in a universal, tax-financed, healthcare system, low-SES ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention face a worse prognosis than high-SES patients.
• The poor outcome seems to be primarily explained by differences in baseline patient characteristics, rather than differences in acute treatment or long-term secondary medical prophylaxis.
• Employment status and income, but not education level, were associated with clinical outcomes.
Clinical Outcomes
The primary end point of this study was major adverse cardiac events (MACE, defined as cardiac death, recurrent myocardial infarction [MI] , and target vessel revascularization) at maximum follow-up. Data on recurrent MI were obtained from The National Patient Registry (information was available until the end of 2009). We defined a recurrent MI as hospitalization for MI occurring >28 days after the index PCI. 16 Deaths were ascertained from the Danish Civil Registration System (information was available until the end of 2010). Data on target vessel revascularization were obtained from the Western Denmark Heart Registry. Target vessel revascularization was defined as a new PCI on the index vessel.
Cause of death was retrieved from the Cause of Death Registry. When a Danish citizen dies, the cause of death is reported using International Classification of Diseases (10th revised edition) diagnosis codes. The following codes defined cardiac death: I0, I1, I20-25, I27, I3, I4, I50, I51, R96, and R99 (information was available until the end of 2009).
Statistical Analyses
The patients were censored at the time of death or followed for up to 8.8 years. Mean follow-up time was 3.7 years. We compared baseline characteristics using Student t test for continuous variables and the χ 2 test for categorical variables. We used Cox proportional-hazards regression to compute crude and adjusted hazard ratios and 95% CIs for the end points in each stratum of income, education, and employment status, using high income, long education, and employed as reference. The proportional hazards assumption was checked for each variable by visual inspection and by using the scaled Schoenfeld residuals. For all measures of SES, the hazards were proportional throughout the follow-up period. All tests of significance were 2-tailed, with P<0.05 considered statistically significant.
First, we adjusted the crude hazard ratios for patient characteristics. To examine the interrelations between the 3 different indicators of SES, we mutually adjusted for socioeconomic factors (eg, models examining the effects of income on mortality were adjusted for education and employment). Next, we added adjustments for the admission findings and procedure-related data. Finally, we added an adjustment for medical treatment during follow-up. All variables listed in onlineonly Data Supplement Table I were included as covariates in the multivariable models. The analyses were repeated in strata of men and women to examine whether sex affected the associations. Because it might be difficult to use employment status, income, and education as a reflection of SES when the patients in question are above retirement age, we repeated the analyses twice while first restricting it to patients <65 years of age and then additionally restricting to patients <60 years of age. The analyses were also repeated without mutual adjustment for socioeconomic factors.
The number of patients with complete data for all measured variables was 2408 (33%). For most variables, only 0.0% to 11% of patients had missing data. However, 23% to 40% of patients had missing data regarding laboratory data; smoking status; and history of hypertension, diabetes mellitus, and hypercholesterolemia. We used multiple imputation to impute missing values for all variables. In addition to all measured variables, we included the event indicator and the Nelson-Aalen estimator of the cumulative hazard to survival time in the imputation model. 17 Analyses were conducted on 5 imputed data sets, and the results were combined using Rubin's rules. 18 To examine the robustness of our analyses, we also conducted complete case analyses restricted to patients with available information about all variables.
We analyzed data using STATA version 11.0 (StataCorp, College Station, TX). Our study was approved by the Danish Data Protection Agency (journal number 2008-41-1835). Table 1 presents the patient characteristics, admission findings and data related to the PPCI procedure, and medical treatment during follow-up according to SES as indicated by income, education, and employment status. In general, female sex, older age, diabetes mellitus, hypertension, previous MI, impaired renal function, anemia, longer duration of symptoms, high Killip class on admission, use of blood transfusions, and high level of comorbidity were more prevalent among low-SES patients than high-SES patients. Low-SES patients were less likely to be treated with glycoprotein IIb/IIIa inhibitors during PPCI; they had a lower TIMI Grade flow after PPCI, more in-lab complications, less successful procedures, and fewer stent implantations. Of the stents implanted, fewer were drug-eluting stents compared with high-SES patients. Low-SES patients were less likely to be treated with statins than high-SES patients but more likely to be treated with diuretics, angiotensin-converting enzyme inhibitors, and nitroglycerin during follow-up. The low-SES patients were more likely to live alone.
Results

Patient and Treatment Characteristics
Low-income patients and pensioners had lower total cholesterol levels than their counterparts. The left main coronary artery was also more likely to be identified as the culprit lesion among low-income patients and pensioners, whereas fewer of these patients were active smokers compared with highincome and employed patients, respectively. When education was used as the indicator of SES, these differences were not present; in contrast, the least educated patients were more likely to be active smokers than their counterparts (for the full table, see online-only Data Supplement Table I) .
Clinical Outcomes
Overall, 1357 patients (18.4%) experienced a MACE during follow-up. Table 2 presents clinical end points after maximum follow-up according to income, education, and employment status. Compared with high-income patients, low-and mediumincome patients had a higher cumulative risk of MACE after maximum follow-up because of a higher incidence of cardiac death and recurrent MI (online-only Data Supplement Table  II) . After adjustment for patient characteristics, the differences in MACE were substantially attenuated and no longer statistically significant. Further adjustment for admission findings, procedure-related data, and medical treatment during followup had very modest effects on the associations.
With education as the indicator of SES, no statistically significant differences were observed in the crude or adjusted hazard ratios of MACE between the groups. Unemployed patients and pensioners had a higher cumulative incidence of MACE after maximum follow-up, primarily explained by higher cardiac mortality and a greater incidence of target vessel revascularization (online-only Data Supplement Table II) . After adjustment for patient characteristics, only the differences in MACE and cardiac mortality after maximum follow-up remained statistically significant. There were no significant changes after further adjustment for admission findings, procedure-related data, and medical treatment during follow-up.
When comparing the cumulative incidence of MACE and cardiac death after 30 days and 1 year and all-cause mortality at 30 days, 1 year, and maximum follow-up, the results were similar (online-only Data Supplement Table II) .
No substantial differences were observed when the analyses were stratified according to sex, the population was restricted to patients <60 or 65 years of age, or without mutually adjusting for socioeconomic factors. Finally, no substantial differences were observed when the findings from the analyses based on the entire study population were compared with the complete case analyses (data not shown).
Discussion
The main findings of our study were that low-SES patients presenting with STEMI and treated with PPCI were older and had a worse baseline risk profile than high-SES patients. These differences could almost entirely explain the poorer crude short-and long-term outcomes in low-SES patients compared with high-SES patients. Differences in admission findings, procedure-related data, and the use of long-term secondary medical prevention only had minor effects. Our study is in accordance with and extends the findings from many other studies, which have observed that SES-related differences in clinical outcome can be either partially 1, 2, 6, 19 or completely 10, 20 ascribed to differences in baseline patient characteristics. However, the possibility of making direct comparisons with and between previously published studies is somewhat limited. SES is a multidimensional concept in which the different dimensions (eg, income, education, and employment status) are closely related. With few exceptions, previously published studies have focused on only a single measure of SES and have consequently been unable to explore the independent roles of the different dimensions of SES. Furthermore, very few studies have included data regarding individual-level SES measures. 1, 20, 21 Various area-based measures of SES have been used-for example, median household income, the proportion of university-educated subjects, and employment rates, as well as composite indexes formed by combining these variables. However, use of area-based measures to estimate an individual's SES results in considerable misclassification and individual-level measures are, therefore, preferred. 22 The finding that employment status and income, rather than education level, were predictors of clinical outcome in our study is also partly in accordance with the results of previous studies. Aside from different area-based SES indexes, income has so far been the most frequently used measure of SES. Most studies focusing on income have observed that differences in clinical outcome persist after adjustment for differences in patient characteristics, 2, 6, 19 although this finding has not been confirmed by all studies. 20 In addition, among studies using education level as the measure of SES, some studies observed differences in outcome that persisted after adjustment for patient characteristics, 1 whereas others observed that differences could be explained by differences in baseline characteristics. 23 One study that used both income and education level as measures of SES observed that income was associated with poor outcomes in all patients, whereas education level was only associated with outcome in patients <65 years of age. 21 It is possible that healthy choices are inculcated early in the Danish school system experience, which might explain why we found no association between educational level and outcome. To our knowledge, no recent studies have examined the role of employment status in relation to outcomes after STEMI. Several studies of MI have reported that high-SES patients are more likely to receive guideline-recommended medications at discharge than are low-SES patients. 5, 6 Other studies have observed that low-income patients were less likely to receive secondary medical prevention after 3 months 24 and that discontinuation of evidence-based medication was associated with not graduating from high school. 25 The latter study also reported that medication therapy discontinuation was associated with higher mortality. To our knowledge, none of the studies regarding SESrelated differences in clinical outcomes after STEMI has included information about secondary medical prevention. Therefore, it is unclear whether the reported SES-related differences in clinical outcome could be mediated by differences in the secondary medical prevention used during follow-up. We observed no substantial SES-related differences in the use of guideline-recommended medications during the PPCI procedure or after 1 or 2 years. Thus, in the setting of a universal, tax-financed, healthcare system, the poor outcomes in low-SES patients seemed not to be explained by differences in acute treatment or long-term secondary medical prevention.
The fact that the poor outcome related to low SES was primarily explained by differences in baseline characteristics, including higher comorbidity, highlights the need for primary prevention strategies. These strategies should be aimed at low-SES groups.
Study Strengths and Limitations
The main strengths of this study are the large number of patients, the long follow-up period, the prospective, population-based design, and the unambiguous individual-level linkage between public data sources. The latter provided detailed information regarding patient characteristics, SES, HR indicates hazard ratio; MACE, major adverse cardiac events (cardiac death, recurrent myocardial infarction and target vessel revascularization).
*Adjusted for patient characteristics and mutual adjustment for socioeconomic factors (see online-only Data Supplement Table I ).
†Adjusted as in * and also for admission findings and procedure-related data (see online-only Data Supplement Table I ). ‡Adjusted as in † and also for medical treatment during follow-up (see online-only Data Supplement Table I ).
treatment and use of medications, and allowed complete follow-up, minimizing the risk of selection bias. Thrombolysis is still widely used in most countries. The mechanisms that determine whether to use thrombolysis or PPCI are unclear. If these mechanisms differ among groups with different SESs, as some studies indicate, 2,4,5 bias may result. The present study was conducted in Denmark, where STEMI patients are almost exclusively treated with PPCI. This clinical situation optimizes external validity and minimizes the risk of bias in this study because the Western Denmark Heart Registry contains data regarding all procedures without any inclusion or exclusion criteria. However, selection bias might be present if the risk of sudden cardiac death before hospital admission is associated with SES. Previous studies indicate that sudden cardiac death is associated with low SES. 26 If this is the case, the SES-associated differences in outcomes that we report may be a conservative estimate of the true difference in outcomes.
The limitations of this study include the use of hospital discharge diagnoses, which may not always be accurate. However, the validity of the majority of the diagnoses included in this study is high. 27 Furthermore, any misclassification is unlikely to depend on SES. Furthermore, although we controlled for a wide range of factors that may affect clinical outcome, we cannot, due to the observational study design, exclude the possibility that confounding factors still influenced the results, including factors for which information was unavailable (eg, lifestyle habits and patient compliance). Race is often closely intertwined with SES 5, 6, 20 and thus might bias the results because race data were unavailable. However, our results are not likely to be substantially biased by race because the population of Denmark is primarily white. Furthermore, although the study size was considerable, the statistical precision of the analyses illustrates that we were not able to completely rule out important effects associated with differences in treatment as well.
Our results might not apply to countries without taxfinanced health care where SES-related differences in care may also contribute to the SES-related differences in clinical outcome. Our findings may, therefore, be a conservative estimate of the SES-related differences in clinical outcome that could be found in such countries.
Conclusions
Even in a universal, tax-financed, healthcare system, low-SES STEMI patients treated with PPCI face a worse prognosis than high-SES patients. The poor outcome seems to be primarily explained by differences in baseline patient characteristics, rather than differences in acute treatment or longterm secondary medical prophylaxis. Employment status and income, but not education level, were associated with clinical outcomes.
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